OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Common NameIUPAC NameIdentification NumbersMinimum degree of purity of the active substancef1 Date of approvalExpiry date of approvalProduct typeSpecific conditions
Peracetic acid generated from tetraacetylethylenediamine and sodium percarbonate

IUPAC Name:

Peroxyethanoic acid

EC No: 201-186-8

CAS No: 79-21-0

Precursors:

  • IUPAC Name: N,N′-ethane-1,2-diylbis(N-acetylacetamide)

    EC No: 234-123-8

    CAS No: 10543-57-4

  • IUPAC Name: Sodium percarbonate

    EC No: 239-707-6

    CAS No: 15630-89-4

The specification for peracetic acid generated in situ is based on the precursors tetraacetylethylenediamine and sodium percarbonate.

The minimum degree of purity of tetraacetylethylenediamine is 99,0 % and the minimum degree of purity of the sodium percarbonate is 85,1 %

1 January 201931 December 20282

The authorisations of biocidal products are subject to the following conditions:

  1. (1)

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

  2. (2)

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:

    1. (a)

      industrial and professional users;

    2. (b)

      surface water for products used in laundry disinfection in closed washing machines in households.

3

The authorisations of biocidal products are subject to the following conditions:

  1. (1)

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

  2. (2)

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.

4

The authorisations of biocidal products are subject to the following conditions:

  1. (1)

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

  2. (2)

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.

Annotations

Footnotes

f1

The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.